期刊文献+

枸橼酸芬太尼对人乳腺癌MCF-7细胞MMP-2及MMP-9表达的影响 被引量:1

Effect of fentanyl on expressions of matrix memlloproteinase-2 and matrix memlloproteinase-9 in human breast cancer MCF-7 cells
原文传递
导出
摘要 目的:探讨枸橼酸芬太尼对人乳腺癌MCF-7细胞MMP-2和MMP-9表达的影响。方法:以MCF-7细胞为对象,分别加入0、0.000 1、0.01、1μmol/L的枸橼酸芬太尼干预48 h,RT-PCR检测MMP-2和MMP-9 mRNA的表达,Western blot检测MMP-2和MMP-9蛋白的表达。结果:MCF-7细胞MMP-2和MMP-9 mRNA的表达随着枸橼酸芬太尼浓度的增加而减少,0.01及1μmol/L枸橼酸芬太尼组与对照组差异有统计学意义(P<0.05)。枸橼酸芬太尼呈浓度依赖性抑制MCF-7细胞MMP-2、MMP-9蛋白的表达,各浓度实验组与对照组差异有统计学意义(P<0.01)。结论:芬太尼可抑制MCF-7细胞MMP-2及MMP-9的表达,该作用可能是芬太尼降低人乳腺癌MCF-7细胞侵袭能力的分子机制之一。 Objective:To explore the effect of fentanyl on expressions of matrix memlloproteinase-2(MMP-2) and matrix memlloproteinase-9(MMP-9) in human breast cancer MCF-7 cells in vitro.Methods:MCF-7 cells were treated respectively with various concentrations of fentanyl for 48 hours.Reverse transcription polymerase-chain reaction(RT-PCR) was used to examine the expressions of MMP-2 and MMP-9 mRNA.Western blot was used to evaluate the productions of MMP-2 and MMP-9 proteins.Results:The expressions of MMP-2 and MMP-9 mRNA in MCF-7 cells decreased after treated with fentanyl.There was statistically significant difference between 0.01 μmol/L,1 μmol/L fentanyl groups and control group(P0.05).The productions of MMP-2 and MMP-9 proteins reduced concentration-dependently when treated with fentanyl.There was statistically significant difference between each experimental group and control group(P0.01).Conclusion:Fentanyl can inhibit the expressions of MMP-2 and MMP-9 in MCF-7 cells,which might be one of the molecule mechanisms of its effectively inhibiting the invasion capacity of MCF-7 cells.
出处 《中国妇幼保健》 CAS 北大核心 2013年第3期525-527,共3页 Maternal and Child Health Care of China
关键词 枸橼酸芬太尼 人乳腺癌细胞 基质金属蛋白酶类 Fentanyl Human breast cancer cell Matrix metallopmteinases
  • 相关文献

参考文献10

  • 1E1 Mouedden M, Meert TF. The impact of the opioids fentanyl and morphine on nociception and bone destruction in a nmrine model of bone cancer pain [ J]. Pharmacol Biochem Behav, 2007, 87 (1): 30.
  • 2丁汉琳,张咸伟,张传汉.芬太尼影响MCF7细胞凋亡的实验研究[J].实用医学杂志,2004,20(12):1351-1353. 被引量:16
  • 3赵海燕,张宏波,张海生,曹文波.枸橼酸芬太尼对乳腺癌细胞体外增殖和侵袭的影响[J].中国妇幼保健,2012,27(1):112-114. 被引量:4
  • 4Folgueras AR, Pend6s AM, S6nchez LM et al. Matrix metallo- proteinases in cancer: from new functions to improved inhibi- tion strategies [J] . Int J Dev Biol, 2004, 48 (5 -6) : 411.
  • 5Pellikainen JM, Ropponen KM, Kataja V: et al. Expression of matrix metalloproteinase (MMP) - 2 and MMP - 9 in breast cancer with a special' reference to activator protein - 2, HER2, and prognosis [J] .Clin Cancer Res, 2004, 10 (22): 7621.
  • 6Kim HJ, Park CI, Park BW. Expression of MT - 1, MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in sitn and invasive ductal carcinoma of the breast [J] . Yonsei Med J, 2006, (3): 333.
  • 7Qi Q, Gu H, Yang Y et al. Involvement of matrix metallopro- teinase 2 and 9 in gambogic acid induced suppression of MDA -MB -435 human breast carcinoma cell lung metastasis [J] .JMolned (Berl), 2008, 86 (12): 1367.
  • 8苏书娟,邢鲁奇,陈登庭,邓淼.MMP-2、MMP-9在乳腺导管癌中表达及意义[J].中国公共卫生,2011,27(3):268-270. 被引量:11
  • 9Daniele A, Zito AF, Giannelli G et al. Expression of metallo- proteinases MMP- 2 and MMP- 9 in sentinel lymph node and serum of patients with metastatic and non - metastatic breast cancer [J] . Anticancer Res, 2010, 30 (9): 3521.
  • 10Gach K, Szemraj J, Wyrebska A et al. The influence of opi- oids on matrix metalloproteinase- 2 and -9 secretion and mRNA levels in MCF - 7 breast cancer cell line [J] . Mol Biol Rep, 2011, 38 (2): 1231.

二级参考文献22

  • 1丁汉琳,张咸伟,张传汉.芬太尼影响MCF7细胞凋亡的实验研究[J].实用医学杂志,2004,20(12):1351-1353. 被引量:16
  • 2张咸伟,丁汉琳,张传汉,田玉科.芬太尼对MCF-7细胞增殖和细胞周期影响研究[J].中国医师杂志,2005,7(1):23-25. 被引量:13
  • 3Bhuvarahamurthy V, Kristiansen GO, Johannsen M, et al. In situ gene expression and localization of metalloproteinases MMP1, MMP2,MMP3 ,MMP9 and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma[J]. Oncol Rep ,2006,15 (5) :1379 - 1384.
  • 4Bartch JE, Staren ED, Appert HE. Matrix metalloproteinase expression in breast cancer[ J]. J Surg Res,2003 ,110(2) :383 -392.
  • 5Shah FD, Shukla SN, Shah PM, et ",d. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer [ J ]. Indian J Cancer, 2009,46( 3 ) : 194 - 202.
  • 6Li HC, Cao DC, Liu Y, et al. Prognostic value of matrix metallo-proteinases (MMP-2 and MMP-9 ) in patients with lymph node- negative breast carcinoma [ J]. Breast Cancer Res Treat, 2004,88 ( 1 ) :75 -85.
  • 7Hatzoglou A, Bakogeorgou E, Castanas E. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors [ J] . Eur J Pharmacol, 1996, 296 (2): 199.
  • 8Hatzoglou A, Ouafik L, Bakogeorgou E et al. Morphine cross -reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth [ J] . Cancer Res, 1995, 55 (23) : 5632.
  • 9El Mouedden M, Meert TF. The impact of the opioids tentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain [J] . Phannacol Biochem Behav, 2007, 87 ( 1 ) : 30.
  • 10Chen YL, Law PY, Loh HH. The other side of the opioid story : modu lation of cell growth and survival signaling [ J ] . Curr Med Chem 2008, /5 (8): 772.

共引文献27

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部